Close Menu

NEW YORK (GenomeWeb) – Applied BioCode said today that it has signed a license and supply agreement for its barcoded magnetic bead (BMB) technology with bioanalytics firm Molecular Devices.

The deal gives Molecular Devices access to specific Applied BioCode BMB patents for use on its own microplate reading devices within the life sciences, food and beverage research, and environmental testing markets. Further details of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.